Pediapharm (CVE:PDP) Stock Price Up 1.7%

Pediapharm Inc. (CVE:PDPGet Free Report) shares rose 1.7% on Wednesday . The stock traded as high as C$0.31 and last traded at C$0.30. Approximately 26,000 shares changed hands during mid-day trading, a decline of 74% from the average daily volume of 100,369 shares. The stock had previously closed at C$0.30.

Pediapharm Stock Up 1.7 %

The company has a debt-to-equity ratio of 186.87, a current ratio of 1.12 and a quick ratio of 0.71. The firm has a market capitalization of C$66.36 million and a P/E ratio of -4.11. The company’s 50-day simple moving average is C$0.30 and its two-hundred day simple moving average is C$0.30.

Pediapharm Company Profile

(Get Free Report)

Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children.

Featured Stories

Receive News & Ratings for Pediapharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediapharm and related companies with MarketBeat.com's FREE daily email newsletter.